2020-005726-29: An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need of adjustment of oral antipsychotic treatment |
|
|
| Not yet recruiting | 4 | 20 | Europe | Capsule, hard, Reagila | Medical University Innsbruck, Gedeon Richter Plc. | Schizophrenia, Schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2021-001268-58: Investigation of effects of cariprazine in patients with mitochondrial schizophrenia A cariprazine hatásának vizsgálata mitochondriális dysfunkcióval asszociált schizophreniában |
|
|
| Not yet recruiting | 4 | 10 | Europe | Reagila, Capsule, Reagila | Semmelweis University, STIA-POC-2020, Semmelweis University, STIA-POC-2020, Gedeon Richter | Mitochondrial disease associated schizophrenia Mitochondrialis betegséghez társuló schizophrenia, schizophrenia associating with mitochondrial disease schizophrenia, amely mitochondrialis betegséghez társul, Psychiatry and Psychology [F] - Behavioral Disciplines and Activities [F04] | | | | |
NCT05384483: Cariprazine Versus Placebo for Social Anxiety Disorder |
|
|
| Not yet recruiting | 4 | 40 | US | Cariprazine, Vraylar®, Placebo | The Medical Research Network, AbbVie | Social Anxiety Disorder | 10/23 | 11/23 | | |